Changes in regulatory T cells in patients with ovarian cancer undergoing surgery: Preliminary results
Authors:
- 1 June 2017
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 47, 244-250
Abstract
No abstract availableKeywords
Funding Information
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- National Natural Science Foundation of China (81371894, 81501817, 81272324)
This publication has 28 references indexed in Scilit:
- Elevated level of peripheral CD8+CD28− T lymphocytes are an independent predictor of progression-free survival in patients with metastatic breast cancer during the course of chemotherapyCancer Immunology, Immunotherapy, 2013
- T-Regulatory Cells: Key Players in Tumor Immune Escape and AngiogenesisCancer Research, 2012
- Role of CD4+CD25+ Regulatory T Cells in Melatonin‐Mediated Inhibition of Murine Gastric Cancer Cell Growth In Vivo and In VitroThe Anatomical Record, 2011
- Increased liver-infiltrating CD8+FoxP3+ regulatory T cells are associated with tumor stage in hepatocellular carcinoma patientsHuman Immunology, 2010
- In situ Vaccination Combined with Androgen Ablation and Regulatory T-Cell Depletion Reduces Castration-Resistant Tumor Burden in Prostate-Specific Pten Knockout MiceCancer Research, 2010
- Identification of CD8 + CD25 + Foxp3 + suppressive T cells in colorectal cancer tissueGut, 2008
- CD4+CD25+ Tregs control the TRAIL-dependent cytotoxicity of tumor-infiltrating DCs in rodent models of colon cancerJournal of Clinical Investigation, 2008
- How regulatory T cells workNature Reviews Immunology, 2008
- CD8+ Foxp3+ Regulatory T Cells Mediate Immunosuppression in Prostate CancerClinical Cancer Research, 2007
- Foxp3 Expressing CD4+ CD25+ and CD8+CD28− T Regulatory Cells in the Peripheral Blood of Patients with Lung Cancer and Pleural MesotheliomaHuman Immunology, 2006